Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients.

PHASE2RecruitingINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2029

Conditions
Relapsed Mantle Cell LymphomaRefractory Mantle Cell Lymphoma
Interventions
DRUG

Consolidation with ADCT-402 (loncastuximab tesirine) after salvage immunochemotherapy at standard dose (R-BAC, Rituximab - Bendamustine, Ara-C))

"Standard Induction phase (cycle 1-2 of R-BAC every 28 days according to the following schedule):~* Rituximab 375 mg/m2 i.v. Day 1~* Bendamustine 70 mg/m2, Days 2 and 3~* Cytarabine 500 mg/m2, Day 2-4~After restaging at the End of Induction (EOI) patients with CR (complete response), PR (partial response) or SD (stable disease) will receive:~CONSOLIDATION PHASE:~* 2 infusions of loncastuximab tesirine at a dose of 150 microgram/kg every three weeks followed by~* 2 infusions of loncastuximab tesirine at a dose of 75 microgram/kg every three weeks"

DRUG

Consolidation with ADCT-402 (loncastuximab tesirine) after salvage immunochemotherapy at reduced dose (R-BAC, Rituximab - Bendamustine, Ara-C)

"Reduced Induction phase (cycle 1-2 with two different schedules for patients deemed FRAIL or UNFIT for standard induction therapy,based on protocol dose and as per medical judgment are allowed).~* Rituximab 375 mg/m2 i.v. Day 1~* Bendamustine 70 mg/m2, Days 2 and 3~* Cytarabine 500 mg/m2, Day 2 and 3~or~* Rituximab 375 mg/m2 i.v. Day 1~* Bendamustine 100 mg, Days 2 and 3~* Cytarabine 500 mg, Day 2 and 3~After restaging at the End of Induction (EOI) patients with CR (complete response), PR (partial response) or SD (stable disease) will receive:~CONSOLIDATION PHASE:~* 2 infusions of loncastuximab tesirine at a dose of 150 microgram/kg every three weeks followed by~* 2 infusions of loncastuximab tesirine at a dose of 75 microgram/kg every three weeks"

Trial Locations (21)

10126

RECRUITING

S.C. Ematologia Universitaria - A.O.U. Città della Salute e della Scienza di Torino, Torino

12100

RECRUITING

S.C. di Ematologia - A.O. S. Croce e Carle, Cuneo

16132

RECRUITING

Ematologia - Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia, Genova

20089

RECRUITING

U.O. Ematologia - Istituto Clinico Humanitas, Rozzano

20133

RECRUITING

Ematologia - Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan

20162

RECRUITING

S.C. Ematologia - ASST Grande Ospedale Metropolitano Niguarda, Milan

25123

RECRUITING

ASST Spedali Civili di Brescia, Brescia

27100

RECRUITING

Divisione di Ematologia - IRCCS Policlinico S. Matteo di Pavia, Pavia

28100

RECRUITING

SCDU Ematologia - AOU Maggiore della Carità di Novara, Novara

31100

RECRUITING

S.C di Ematologia - Ospedale Ca Foncello, Treviso

34121

RECRUITING

SC Ematologia - Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste

37134

RECRUITING

U.O. Ematologia - AOU Integrata di Verona, Verona

42123

RECRUITING

Ematologia - Azienda Unitа Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova, Reggio Emilia

47923

RECRUITING

U.O. di Ematologia - Ospedale degli Infermi di Rimini, Rimini

48121

RECRUITING

Ematologia - Ospedale delle Croci, Ravenna

50141

RECRUITING

Unità funzionale di Ematologia - Azienda Ospedaliera Universitaria Careggi, Florence

73039

RECRUITING

U.O.C Ematologia e Trapianto - A.O. C. Panico, Tricase

80131

RECRUITING

UOC Ematologia Oncologica - Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale, Napoli

90146

RECRUITING

Divisione di Ematologia - A.O. Ospedali Riuniti Villa Sofia-Cervello, Palermo

Unknown

RECRUITING

"S.C. Ematologia - A.S.O. SS Antonio e Biagio e Cesare Arrigo", Alessandria

00161

RECRUITING

"Dipartimento di Medicina Traslazionale e di Precisione - Policlinico Umberto I - Università La Sapienza Istituto Ematologia", Roma

All Listed Sponsors
lead

Fondazione Italiana Linfomi - ETS

OTHER